Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Novel protein pseudogene" (ENSG00000288567) refers to a **pseudogene**, which is a DNA segment that resembles a functional protein-coding gene but is generally nonfunctional due to sequence disruptions (such as frame shifts or premature stop codons) or lack of regulatory elements required for gene expression[1][2][3]. Pseudogenes can be created by duplication or retrotransposition but nearly always lack protein-coding capacity. While extremely rare pseudogenes may be expressed and exert regulatory or even protein functions, in almost all cases—including the general category "novel protein pseudogene"—these are nonfunctional genetic elements[2][3]. Large-scale surveys indicate pseudogenes are prevalent throughout the genome and may sometimes be misannotated as functional genes in sequence databases[2][3]. Context: - "Novel protein pseudogene" is a general genome annotation, not a specific receptor, enzyme, or molecular target. - *ENSG00000288567* is listed as a pseudogene because it shares sequence similarity to known protein-coding genes but lacks evidence for producing a functional protein[1][3]. - Pseudogenes are common in the human genome (~12,000–14,000 identified), and many are remnants of past duplication or retrotransposition events[2][3]. - They are typically not considered druggable targets or associated with established roles in disease or therapeutics, though an extremely small subset have regulatory RNA roles[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel protein pseudogene.